Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice

Nonalcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance. The peroxisome proliferator-activated receptor (PPAR) activators, thiazolidinediones, (TZDs), are insulin sensitizers used as a treatment for NAFLD. However, TZDs are a controversial treatment for NAFLD because...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PPAR Res
Autori principali: Choung, Sorim, Joung, Kyong Hye, You, Bo Ram, Park, Sang Ki, Kim, Hyun Jin, Ku, Bon Jeong
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi 2018
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6020545/
https://ncbi.nlm.nih.gov/pubmed/30008738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/4292509
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi